Shanghai RAAS Blood Products Co., Ltd.
002252
Rankning i aktier
#3642
Shanghai RAAS Blood Products Co., Ltd. engages in the research, development,... Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. It provides human albumin, intravenous injection of human immunoglobulin, coagulation factor products, vaccines, diagnostic reagents, and testing services. The company was founded by Kieu Hoang on October 29, 1988 and is headquartered in Shanghai, China.
Aktiekurs
$0.70717976
Marknadsvärde
$4.66B
Förändring (1 dag)
-0.20%
Förändring (1 år)
-24.51%
Land
CN
Handel Shanghai RAAS Blood Products Co., Ltd. (002252)
Kategori
Healthcare
EPS för Shanghai RAAS Blood Products Co., Ltd. (002252)
EPS per June 2026 TTM: $0.03
Enligt Shanghai RAAS Blood Products Co., Ltd.s senaste finansiella rapporter och aktiekurs är bolagets nuvarande EPS (TTM) $0.03. Vid slutet av 2023 hade bolaget ett EPS på $0.04, lika med EPS från 2022 som var $0.04.
EPS-historik för Shanghai RAAS Blood Products Co., Ltd. från 2005 till 2026
EPS vid slutet av varje år
| År | EPS | Ändra |
|---|---|---|
| 2026 (TTM) | $0.03 | -47.80% |
| 2024 | $0.05 | 18.64% |
| 2023 | $0.04 | -6.16% |
| 2022 | $0.04 | 34.44% |
| 2021 | $0.03 | 0.33% |
| 2020 | $0.03 | 75.00% |
| 2019 | $0.02 | -138.14% |
| 2018 | $-0.05 | -272.80% |
| 2017 | $0.03 | -45.05% |
| 2016 | $0.05 | 6.26% |
| 2015 | $0.04 | 130.41% |
| 2014 | $0.02 | 203.13% |
| 2013 | $0.01 | -37.25% |
| 2012 | $0.01 | 12.09% |
| 2011 | $0.01 | 13.75% |
| 2010 | $0.01 | 40.35% |
| 2009 | $0.01 | 14.00% |
| 2008 | $0.01 | 19.05% |
| 2007 | 0.00 | -38.24% |
| 2006 | $0.01 | 3.03% |
| 2005 | $0.01 | 0.00% |
EPS för liknande företag eller konkurrenter
| Företag | EPS | EPS-differens | Land |
|---|---|---|---|
| $17.32 | 66,260.15% |
US
|
|
| $-7.98 | -30,674.71% |
US
|
|
| $-5.29 | -20,368.20% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | 106,183.52% |
NL
|
